Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Passage of treatments at the blood-brain barrier

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 11.05.18
Views: 501

Prof William Elmquist - University of Minnesota, Minneapolis, USA

Prof Elmquist speaks with ecancer at Cancer Research UK Brain Tumour Conference 2018 in London about the effect of drug permeability at the blood-brain barrier on treatment prospects.

He describes potential strategies to improve drug delivery, such as inhibiting transporter proteins and utilising nanoparticles, and outlines his work with patient derived xenografts and new imaging techniques to assess treatment efficacy.

Related videos

follow us

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation